Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;34(12):1645-1651.
doi: 10.1007/s10815-017-1034-z. Epub 2017 Sep 4.

Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve

Affiliations
Free PMC article

Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve

Mario Mignini Renzini et al. J Assist Reprod Genet. 2017 Dec.
Free PMC article

Abstract

Purposes: The aim of this study is to determine whether a clinical advantage is gained with use of LH in combination with FSH or as a component of human menopausal gonadotropin (hMG) to achieve optimal ovarian stimulation.

Methods: In this study, we compared retrospectively two regimens, r-FSH/r-LH and hMG, for the treatment of women with reduced ovarian reserve, identified as subjects with antral follicle count (AFC) < 11 and AMH ≤ 1.1 ng/ml.

Results: Overall, the clinical pregnancy per started cycle was higher in the r-FSH/r-LH group (12.5 vs. 8.1%, P < 0.02), while implantation (11.1 vs. 9.5%) and miscarriage rates (29.9 vs. 35.9%) were comparable. Data were further analysed performing separate comparisons in subpopulations with different ranges of AFC, i.e. < 4, 4-6 and 7-10. Major differences between the two regimens were observed in women with AFC < 4. In this subpopulation, not only was the clinical pregnancies per started cycle higher in the r-FSH/r-LH group (10.2 vs. 1.5%, P < 0.01), but also implantation was significantly higher (13.0 vs. 2.8%, P < 0.02).

Conclusions: A r-FSH/r-LH regimen appears to be beneficial for the treatment of women with extremely poor ovarian reserve. It should be considered however that, being retrospective, this study is affected by obvious limitations, such as post-treatment patient selection criteria and absence of randomisation.

Keywords: FSH; IVF; LH; Ovarian reserve; Ovarian stimulation; Poor responders; Pregnancy; hMG.

PubMed Disclaimer

Conflict of interest statement

The study was approved by the competent ethical committee (San Gerardo Hospital, Monza, Italy). Written informed consent was obtained from all couples before starting treatment.

Similar articles

Cited by

References

    1. Orvieto R, Patrizio P. GnRH agonist versus GnRH antagonist in ovarian stimulation: an ongoing debate. Reprod BioMed Online. 2013;26:4–8. doi: 10.1016/j.rbmo.2012.11.001. - DOI - PubMed
    1. Xiao J-S, Su C-M, Zeng X-T. Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis. Tian X, editor. PLoS One. Public Library of Science; 2014; 9:e106854. - PMC - PubMed
    1. Fatemi HM, Popovic-Todorovic B, Humaidan P, Kol S, Banker M, Devroey P, et al. Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and “freeze-all” approach in GnRH antagonist protocol. Fertil Steril. 2014;101:1008–1011. doi: 10.1016/j.fertnstert.2014.01.019. - DOI - PubMed
    1. Baerwald AR, Adams GP, Pierson RA. Ovarian antral folliculogenesis during the human menstrual cycle: a review. Hum Reprod Update. 2012;18:73–91. doi: 10.1093/humupd/dmr039. - DOI - PubMed
    1. Hillier SG, Smyth CD, Whitelaw PF, Miró F, Howles CM. Gonadotrophin control of follicular function. Horm Res. 1995;43:216–223. doi: 10.1159/000184282. - DOI - PubMed